Please assess the completion status of the following clinical trial:

Trial Title: Role of Positron Emission Mammography (PEM) Flex Solo II Positron Emission Tomography (PET) Scanner in Evaluating Neoadjuvant Chemotherapy Response in Patients With Breast Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Women 18-75 years old with newly diagnosed breast cancer who are considered candidates for breast conserving surgery (i.e., lumpectomy)~Exclusion Criteria:~* Children (\< 18 years old)~* Pregnant or Lactating women~* Diabetic patients (Type I or II)~* Patients who are scheduled for a sentinel node procedure using radioactive Tc-99m within 24 hours of PEM~* Patients who have NOT undergone a standard of care bilateral breast MRI

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Beast cancer subjects (Type: EXPERIMENTAL): Subject will have assessment of neoadjuvant chemotherapy treatment response by both MRI and PEM to compare methods

Based on this trial design, predict the completion outcome and termination type (if applicable).